BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26473932)

  • 1. Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients.
    Helbo AS; Treppendahl M; Aslan D; Dimopoulos K; Nandrup-Bus C; Holm MS; Andersen MK; Liang G; Kristensen LS; Grønbæk K
    Genes (Basel); 2015 Oct; 6(4):977-90. PubMed ID: 26473932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer chromatin analysis of the human vtRNA genes uncovers their association with cancer biology.
    Fort RS; Duhagon MA
    F1000Res; 2021; 10():182. PubMed ID: 34354812
    [No Abstract]   [Full Text] [Related]  

  • 3. Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6.
    Chen J; OuYang H; An X; Liu S
    PLoS One; 2018; 13(1):e0191325. PubMed ID: 29346433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome.
    Kaastrup K; Gillberg L; Mikkelsen SU; Ørskov AD; Schöllkopf C; Mortensen BK; Porse B; Hansen JW; Grønbæk K
    Clin Epigenetics; 2023 May; 15(1):91. PubMed ID: 37237325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.
    Rüter B; Wijermans PW; Lübbert M
    Int J Hematol; 2004 Aug; 80(2):128-35. PubMed ID: 15481440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.
    Yang Y; Zhang Q; Xu F; Chang C; Li X
    Eur J Haematol; 2012 Dec; 89(6):469-77. PubMed ID: 23005040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome.
    Yang Y; Zhang Q; Xu F; Wu L; He Q; Li X
    J Cancer Res Clin Oncol; 2012 May; 138(5):729-37. PubMed ID: 22246278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced rRNA expression and increased rDNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes.
    Raval A; Sridhar KJ; Patel S; Turnbull BB; Greenberg PL; Mitchell BS
    Blood; 2012 Dec; 120(24):4812-8. PubMed ID: 23071274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decitabine in the treatment of myelodysplastic syndromes.
    Santos FP; Kantarjian H; Garcia-Manero G; Issa JP; Ravandi F
    Expert Rev Anticancer Ther; 2010 Jan; 10(1):9-22. PubMed ID: 20014881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML.
    Treppendahl MB; Qiu X; Søgaard A; Yang X; Nandrup-Bus C; Hother C; Andersen MK; Kjeldsen L; Möllgård L; Hellström-Lindberg E; Jendholm J; Porse BT; Jones PA; Liang G; Grønbæk K
    Blood; 2012 Jan; 119(1):206-16. PubMed ID: 22058117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation of the candidate tumor suppressor gene TCF21 in myelodysplastic syndrome and acute myeloid leukemia.
    Gu Y; Zhou JD; Xu ZJ; Zhang TJ; Wen XM; Ma JC; Ji RB; Yuan Q; Zhang W; Chen Q; Lin J; Qian J
    Am J Transl Res; 2019; 11(6):3450-3460. PubMed ID: 31312357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
    Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia.
    Wong JJ; Lau KA; Pinello N; Rasko JE
    Cancer Sci; 2014 Nov; 105(11):1457-63. PubMed ID: 25220401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
    Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
    Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.
    Hopfer O; Komor M; Koehler IS; Freitag C; Schulze M; Hoelzer D; Thiel E; Hofmann WK
    Leuk Res; 2009 Mar; 33(3):434-42. PubMed ID: 18829110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.
    Ye Y; McDevitt MA; Guo M; Zhang W; Galm O; Gore SD; Karp JE; Maciejewski JP; Kowalski J; Tsai HL; Gondek LP; Tsai HC; Wang X; Hooker C; Smith BD; Carraway HE; Herman JG
    Cancer Res; 2009 Nov; 69(21):8482-90. PubMed ID: 19826047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level.
    Nilsson L; Astrand-Grundström I; Arvidsson I; Jacobsson B; Hellström-Lindberg E; Hast R; Jacobsen SE
    Blood; 2000 Sep; 96(6):2012-21. PubMed ID: 10979941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Expression and Methylation Pattern in HRK Apoptotic Gene in Myelodysplastic Syndrome.
    Zaker F; Amirizadeh N; Nasiri N; Razavi SM; Teimoori-Toolabi L; Yaghmaie M; Mehrasa R
    Int J Mol Cell Med; 2016; 5(2):90-9. PubMed ID: 27478805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.
    Schmelz K; Sattler N; Wagner M; Lübbert M; Dörken B; Tamm I
    Leukemia; 2005 Jan; 19(1):103-11. PubMed ID: 15510208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.